Medicus Pharma signs share exchange agreement to acquire Antev Limited

Medicus Pharma Ltd.

Agreement to acquire all Antev Shares; Antev becomes wholly-owned subsidiary of Medicus.
Consideration includes Purchaser Shares (Consideration Shares) and Contingent Consideration tied to milestones.
Antev's lead candidate Teverelix (for acute urinary retention) referenced in forward-looking statements.
Closing expected 3 Business Days after conditions satisfied; drag-along provisions apply for all shareholders.

item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.